| Dec 31, 2021 | Dec 31, 2022 |
---|
Cash and cash equivalents | 64 | 63 |
---|
Accounts receivable, net | 18 | 26 |
---|
Prepaid expenses | - | 6 |
---|
Other current assets | - | 2 |
---|
Total current assets | 90 | 97 |
---|
Property and equipment, net | 13 | 16 |
---|
Right-of-use assets, net | - | 7 |
---|
Other assets | 3 | 4 |
---|
Total assets | 106 | 124 |
---|
Accounts payable | 3 | 2 |
---|
Accrued expenses and other current liabilities | 6 | 12 |
---|
Operating Lease, Liability, Current | - | 4 |
---|
Total current liabilities | 8 | 17 |
---|
Operating Lease, Liability, Noncurrent | - | 3 |
---|
Other liabilities | 1 | - |
---|
Total liabilities | 9 | 20 |
---|
Common Class A | 0 | 0 |
---|
Common Class B | 0 | 0 |
---|
Additional paid-in capital | 227 | 244 |
---|
Accumulated deficit | -171 | -179 |
---|
Accumulated other comprehensive loss | -0 | -1 |
---|
Total stockholders' equity attributable to Enfusion, Inc. | 97 | 103 |
---|
Non-controlling interests | 42 | 38 |
---|
Common Class A | 0 | 0 |
---|
Common Class B | 0 | 0 |
---|
Total stockholders' equity | 97 | 103 |
---|
Total liabilities and stockholders' equity | 106 | 124 |
---|